Photobiomodulation Therapy Offers New Hope for Dry Macular Degeneration Patients

Paul Vision Institute in Wilmington, North Carolina, is introducing photobiomodulation (PBM) therapy as a non-invasive treatment for patients with dry age-related macular degeneration (AMD). PBM utilizes light-based therapy to support retinal cellular function and potentially improve visual performance.

Dr. Edward Paul stated, "Photobiomodulation changes the conversation for dry AMD. This non-invasive treatment offers patients a proactive approach to preserving vision—and new hope." Age-related macular degeneration is a leading cause of significant vision loss among adults over age 50, impacting daily activities such as reading and driving. (einnews.com)